MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr-/-Apob100/100 mouse

International Journal of Molecular Medicine

Volumn 28, Issue 2, 2011, Pages 247-253

  Dick, Wågsäter ^a   Zhu, Chaoyong ^a   Björkegren, Johan ^a   Skogsberg, Josefin ^a   Eriksson, Per ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apolipoprotein B 100; Atherosclerosis; Extracellular matrix; Protease

Indexed keywords

COLLAGEN; COLLAGENASE 3; GELATINASE A; GELATINASE B; MESSENGER RNA; NEUTROPHIL COLLAGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

ANIMALS; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; GELATINASES; GENE EXPRESSION REGULATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TIME FACTORS;

EID: 79958135357     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.693     Document Type: Article

References (19)

1. Hansson GK, Robertson AK and Soderberg-Naucler C: Inflammation and atherosclerosis. Annu Rev Pathol 1: 297-329, 2006.
2. Newby AC: Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85: 1-31, 2005.
3. Johnson JL, George SJ, Newby AC and Jackson CL: Divergent effects of matrix metalloproteinases 3,7,9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc Natl Acad Sci USA 102: 15575-15580, 2005.
4. Nilsson L, Jonasson L, Nijm J, Hamsten A and Eriksson P: Increased plasma concentration of matrix metalloproteinase-7 in patients with coronary artery disease. Clin Chem 52: 1522-1527, 2006. (Pubitemid 44148315)
5. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, Meyer J, Cambien F and Tiret L: Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107: 1579-1585, 2003. (Pubitemid 36397324)
6. Farese RV Jr, Veniant MM, Cham CM, Flynn LM, Pierotti V, Loring JF, Traber M, Ruland S, Stokowski RS, Huszar D and Young SG: Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. Proc Natl Acad Sci USA 93: 6393-6398, 1996. (Pubitemid 26230316)
7. Skogsberg J, Lundstrom J, Koracs A, Nilsson R, Noori P, Maleki S, Kohler M, Hamsten A, Tegner J and Bjorkegren J: Transcriptional profiling uncovers a network of cholesterol-responsive atherosclerosis target genes. PLoS Genet 4: e1000036, 2008.
8. Wagsater D, Bjork H, Zhu C, Bjorkegren J, Valen G, Hamsten A and Eriksson P: ADAMTS-4 and -8 are inflammatory regulated enzymes expressed in macrophage-rich areas of human atherosclerotic plaques. Atherosclerosis 196: 514-522, 2008.
9. Lieu HD, Withycombe SK, Walker Q, Rong JX, Walzem RL, Wong JS, Hamilton RL, Fisher EA and Young SG: Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion. Circulation 107: 1315-1321, 2003. (Pubitemid 36314417)
10. Deguchi JO, Aikawa E, Libby P, Vachon JR, Inada M, Krane SM, Whittaker P and Aikawa M: Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation 112: 2708-2715, 2005. (Pubitemid 41532609)
11. Luque EH, Angulo E and Montes GS: A histochemical and electron microscopic study on the collagen of nerves in the domestic fowl. J Anat 137: 171-176, 1983. (Pubitemid 13042219)
12. Yan L, Borregaard N, Kjeldsen L and Moses MA: The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 276: 37258-37265, 2001.
13. Monier F, Surla A, Guillot M and Morel F: Gelatinase isoforms in urine from bladder cancer patients. Clin Chim Acta 299: 11-23, 2000. (Pubitemid 30438786)
14. Whatling C, Bjork H, Gredmark S, Hamsten A and Eriksson P: Effect of macrophage differentiation and exposure to mildly oxidized LDL on the proteolytic repertoire of THP-1 monocytes. J Lipid Res 45: 1768-1776, 2004. (Pubitemid 39296217)
15. Yan C and Boyd DD: Regulation of matrix metalloproteinase gene expression. J Cell Physiol 211: 19-26, 2007. (Pubitemid 46363892)
16. Jormsjo S, Wuttge DM, Sirsjo A, Whatling C, Hamsten A, Stemme S and Eriksson P: Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 161: 939-945, 2002. (Pubitemid 34988381)
17. Sukhova GK, Zhang Y, Pan JH, Wada Y, Yamamoto T, Naito M, Kodama T, Tsimikas S, Witztum JL, Lu ML, Sakara Y, Chin MT, Libby P and Shi GP: Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest 111: 897-906, 2003. (Pubitemid 37074965)
18. Sternlicht MD and Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516, 2001. (Pubitemid 33096184)
19. Yamada S, Wang KY, Tanimoto A, Fan J, Shimajiri S, Kitajima S, Morimoto M, Tsutsui M, Watanabe T, Yasumoto K and Sasaguri Y: Matrix metalloproteinase 12 accelerates the initiation of atherosclerosis and stimulates the progression of fatty streaks to fibrous plaques in transgenic rabbits. Am J Pathol 172: 1419-1429, 2008. (Pubitemid 351671554)